Pathophysiology of glycaemic and cardiovascular risk factors in diabetes
Prof. Paul is leading a research program to evaluate the long-term effects of glycaemic and other risk factors on cardiovascular and mortality risks in patients with diabetes. This programme of studies is based on the longitudinal electronic data on about 2.5 million patients with diabetes and non-diabetic controls, from primary care and ambulatory care databases of UK and USA.
Prof Sanjoy Paul, Director
- Professor Azeem Majeed, Imperial College London, UK
- Professor Kamlesh Khunti, University of Leicester, UK
Industry grants from Novo Nordisk and AstraZeneca
Paul SK, Klein K, Majeed A, Khunti K. Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes. Journal of Diabetes. 2016;8(3):354-62.